Richard A. Guarino, M.D., President, Oxford Pharmaceutical Resources, Inc.
Richard A. Guarino, M.D. is President of Oxford Pharmaceutical Resources, Inc., a consulting organization specializing in the planning, implementing and submitting of INDs, NDAs and CTDs. Dr. Guarino also has 25 years of experience in new drug applications, in marketing launches, advertising, and FDA liaison.
Dr. Guarino was formerly the President and CEO of Oxford Research International Corp., one of the largest CROs in the United States. Besides serving as an adjunct professor at Fairleigh Dickinson University, he was a former Director of Clinical Research at Sandoz Pharmaceutical Inc., now Novartis, and held the position of Vice President/Medical Director at Revlon Healthcare Group. He has been acclaimed for his book, New Drug Approval Process, now in its 4th edition. It is the first book ever written to guide and recommend ways to expedite global new drug approval process while following all the requirements of the Code of Federal Regulations and EU Directives.
Dr. Guarino is a member of many professional societies and associations including the New Jersey and New York Academies of Medicine, The Royal Society of Medicine, the Columbus Citizens Foundation, the Presidential Advisory Cabinet at Fairleigh Dickinson University, the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Columbus Foundation, Drug Information Association (DIA), Association of Clinical Research Professionals (ACRP), and Academy of Pharmaceutical Physicians and Investigators (APPI).
|